Subscribe
Our latest screen highlights some ambitious growth plays and one shifts in strategy
Does the sector offer value out of post-pandemic doldrums?
Politics is exasperating but investors can look after themselves
Finding quality compounders amid a fundamentally changed backdrop
Earnings growth forecasts must be balanced against valuation
Options for growth at a more reasonable price
In case trade headaches hit big dividend payers is it time to look at mid-caps?
Trade war should prompt reflection over which shares are quality compounders
Valuation risk remains key in volatile markets
Growth on a more reasonable price after recent selling
